BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 18922680)

  • 1. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
    Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
    J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
    Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
    J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
    Leighty L; Li N; Diaz LA; Liu Z
    Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
    Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
    J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
    Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
    Front Immunol; 2019; 10():1410. PubMed ID: 31275329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
    Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
    J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
    Fang H; Zhang Y; Li N; Wang G; Liu Z
    Front Immunol; 2018; 9():407. PubMed ID: 29545809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects on the pathogenesis of bullous pemphigoid].
    Schmidt E; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.
    Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of BP230 autoantibodies in bullous pemphigoid.
    Shih YC; Wang B; Yuan H; Zheng J; Pan M
    J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients.
    Di Zenzo G; Grosso F; Terracina M; Mariotti F; De Pità O; Owaribe K; Mastrogiacomo A; Sera F; Borradori L; Zambruno G
    J Invest Dermatol; 2004 Jan; 122(1):103-10. PubMed ID: 14962097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
    Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.
    Messingham KA; Holahan HM; Fairley JA
    Immunol Res; 2014 Aug; 59(1-3):273-8. PubMed ID: 24845463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
    Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D
    J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.
    Fairley JA; Fu CL; Giudice GJ
    J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.